Imaging techniques in nuclear cardiology for the assessment of myocardial viability

International Journal of Cardiovascular Imaging

Volumn 22, Issue 1, 2006, Pages 63-80

  Slart, Riemer H J A ^a   Bax, Jeroen J ^b   van Veldhuisen, Dirk J ^a   van der Wall, Ernst E ^b   Dierckx, Rudi A J O ^a   Jager, Pieter L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Combined cameras; Myocardial viability; Nuclear cardiac techniques; Radiopharmaceuticals; Review

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OXYGEN 15; RUBIDIUM 82; TETROFOSMIN TC 99M; THALLIUM 201; TRACER;

ANGIOCARDIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REST; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS;

EID: 33644855976     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1007/s10554-005-7514-8     Document Type: Review

References (138)

1. MF Carli Di, M Davidson and R Little, Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73 (1994) 527-533
2. SH Rahimtoola, The hibernating myocardium. Am Heart J 117 (1989) 211-221
3. J Tillisch, R Brunken and R Marshall, Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314 (1986) 884-888
4. V Dilsizian, TP Rocco, NM Freedman, MB Leon and RO Bonow, Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323 (1990) 141-146
5. N Tamaki, M Kawamoto and E Tadamura, Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 91 (1995) 1697-1705
6. RO Bonow, Identification of viable myocardium. Circulation 94 (1996) 2674-2680
7. M Emond, MB Mock and KB Davis, Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90 (1994) 2645-2657
8. DW Baker, R Jones, J Hodges, BM Massie, MA Konstam and EA Rose, Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 272 (1994) 1528-1534
9. EP Bounous, DB Mark and BG Pollock, Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 78 (1988) I151-I157
10. M Ragosta, GA Beller, DD Watson, S Kaul and LW Gimple, Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 87 (1993) 1630-1641
11. N Tamaki, Y Yonekura and K Yamashita, Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 64 (1989) 860-865
12. E Braunwald and RA Kloner, The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66 (1982) 1146-1149
13. RA Kloner, R Bolli, E Marban, L Reinlib and E Braunwald, Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop. Circulation 97 (1998) 1848-1867
14. E Braunwald and JD Rutherford, Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium". J Am Coll Cardiol 8 (1986) 1467-1470
15. GD Dispersyn, J Ausma and F Thone, Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: Prelude to apoptosis. Cardiovasc Res 43 (1999) 947-957
16. JM Wilson, Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J 26 (1999) 19-27
17. A Elsasser, M Schlepper and R Zimmermann, The extracellular matrix in hibernating myocardium-a significant factor causing structural defects and cardiac dysfunction. Mol Cell Biochem 186 (1998) 147-158
18. NG Frangogiannis, The pathological basis of myocardial hibernation. Histol Histopathol 18 (2003) 647-655
19. JL Vanoverschelde, C Depre and BL Gerber, Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 85 (2000) 1432-1439
20. RA Gottlieb, KO Burleson, RA Kloner, BM Babior and RL Engler, Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621-1628
21. JF Kerr, AH Wyllie and AR Currie, Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
22. A Haunstetter and S Izumo, Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 82 (1998) 1111-1129
23. MF Carli Di, M Davidson and R Little, Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73 (1994) 527-533
24. R Zimmermann, G Mall and B Rauch, Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation 91 (1995) 1016-1021
25. FM Baer, E Voth, CA Schneider, P Theissen, H Schicha and U Sechtem, Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 91 (1995) 1006-1015
26. FM Baer, E Voth and HJ Deutsch, Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 28 (1996) 60-69
27. U Qureshi, SF Nagueh and I Afridi, Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. Circulation 95 (1997) 626-635
28. M Leoncini, R Sciagra and M Maioli, Usefulness of dobutamine Tc-99m sestamibi-gated single-photon emission computed tomography for prediction of left ventricular ejection fraction outcome after coronary revascularization for ischemic cardiomyopathy. Am J Cardiol 89 (2002) 817-821
29. JE Udelson, PS Coleman and J Metherall, Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 89 (1994) 2552-2561
30. J vom-Dahl, DT Eitzman and ZR al Aouar, Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90 (1994) 2356-2366
31. JJ Bax, D Poldermans and A Elhendy, Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 (1999) 163-169
32. MF Carli Di, F Asgarzadie and HR Schelbert, Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92 (1995) 3436-3444
33. PW Thimister, L Hofstra and IH Liem, In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44 (2003) 391-396
34. A Maes, W Flameng and J Nuyts, Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 90 (1994) 735-745
35. MJ Knuuti, M Saraste and P Nuutila, Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 127 (1994) 785-796
36. G Lucignani, G Paolini and C Landoni, Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 19 (1992) 874-881
37. AF Maes, M Borgers and W Flameng, Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 29 (1997) 62-68
38. H Schoder, R Campisi and T Ohtake, Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 33 (1999) 1328-1337
39. LH Opie, Metobolism of the heart in health and disease. I. Am Heart J 76 (1968) 685-698
40. LH Opie, Metabolism of the heart in health and disease. II. Am Heart J 77 (1969) 100-122
41. LH Opie, Metabolism of the heart in health and disease. 3. Am Heart J 77 (1969) 383-410
42. P Camici, E Ferrannini and LH Opie, Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 32 (1989) 217-238
43. LM King and LH Opie, Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res 39 (1998) 381-392
44. LH Opie, Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 38 (1976) I52-I74
45. MJ Knuuti, H Yki-Jarvinen and LM Voipio-Pulkki, Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 35 (1994) 989-998
46. JJ Bax, MA Veening and FC Visser, Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 24 (1997) 35-41
47. F Haas, CJ Haehnel and W Picker, Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30 (1997) 1693-1700
48. N Tamaki, M Kawamoto and N Takahashi, Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 22 (1993) 1621-1627
49. MJ Knuuti, P Nuutila and U Ruotsalainen, The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 34 (1993) 2068-2075
50. SR Bergmann, Cardiac positron emission tomography. Semin Nucl Med 28 (1998) 320-340
51. TL Rosamond, DR Abendschein and BE Sobel, Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: Implications for positron emission tomography. J Nucl Med 28 (1987) 1322-1329
52. GD Hutchins, M Schwaiger, KC Rosenspire, J Krivokapich, H Schelbert and DE Kuhl, Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15 (1990) 1032-1042
53. H Iida, I Kanno and A Takahashi, Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 78 (1988) 104-115
54. JJ Bax, FC Visser and D Poldermans, Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 104 (2001) I314-I318
55. F Haas, N Augustin and K Holper, Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: Correlation with positron emission tomographic findings. J Am Coll Cardiol 36 (2000) 1927-1934
56. F Haas, L Jennen and U Heinzmann, Ischemically compromised myocardium displays different time-courses of functional recovery: Correlation with morphological alterations?. Eur J Cardiothorac Surg 20 (2001) 290-298
57. HR Schelbert, ME Phelps and SC Huang, N-13 ammonia as an indicator of myocardial blood flow. Circulation 63 (1981) 1259-1272
58. S Sawada, O Muzik, RS Beanlands, E Wolfe, GD Hutchins and M Schwaiger, Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol 2 (1995) 413-422
59. M Endo, K Yoshida and TA Iinuma, Noninvasive quantification of regional myocardial blood flow and ammonia extraction fraction using nitrogen-13 ammonia and positron emission tomography. Ann Nucl Med 1 (1987) 1-6
60. J Krivokapich, GT Smith and SC Huang, 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80 (1989) 1328-1337
61. J Krivokapich, LW Stevenson, J Kobashigawa, SC Huang and HR Schelbert, Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 18 (1991) 512-517
62. O Muzik, RS Beanlands, GD Hutchins, TJ Mangner, N Nguyen and M Schwaiger, Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 34 (1993) 83-91
63. S Nagamachi, J Czernin and AS Kim, Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 37 (1996) 1626-1631
64. AN Kitsiou, SL Bacharach and ML Bartlett, 13N-ammonia myocardial blood flow and uptake: Relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 33 (1999) 678-686
65. SC Huang, M Schwaiger and RE Carson, Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: An assessment of potential and problems. J Nucl Med 26 (1985) 616-625
66. EU Nitzsche, Y Choi, J Czernin, CK Hoh, SC Huang and HR Schelbert, Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation 93 (1996) 2000-2006
67. R Silva De, Y Yamamoto and CG Rhodes, Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 86 (1992) 1738-1742
68. Y Yamamoto, R Silva De and CG Rhodes, A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography. Circulation 86 (1992) 167-178
69. L Becker, R Ferreira and M Thomas, Comparison of 86Rb and microsphere estimates of left ventricular bloodflow distribution. J Nucl Med 15 (1974) 969-973
70. RA Goldstein, NA Mullani, SK Marani, DJ Fisher, KL Gould and H-AJ O'Brien, Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 24 (1983) 907-915
71. KL Gould, Identifying and measuring severity of coronary artery stenosis. Quantitative coronary arteriography and positron emission tomography. Circulation 78 (1988) 237-245
72. M Grover-McKay, O Ratib and M Schwaiger, Detection of coronary artery disease with positron emission tomography and rubidium 82. Am Heart J 123 (1992) 646-652
73. HL Boyd, RN Gunn and NV Marinho, Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography. Eur J Nucl Med 23 (1996) 1594-1602
74. EJ Hoffman, ME Phelps, G Wisenberg, HR Schelbert and DE Kuhl, Electrocardiographic gating in positron emission computed tomography. J Comput Assist Tomogr 3 (1979) 733-739
75. N Hattori, FM Bengel and J Mehilli, Global and regional functional measurements with gated FDG PET in comparison with left ventriculography. Eur J Nucl Med 28 (2001) 221-229
76. HM Hoffmeister, U Helber and A Franow, ECG-gated 18F-FDG positron emission tomography. Int J Cardiovasc Imaging 18 (2002) 363-372
77. G Hor, WT Kranert and FD Maul, Gated metabolic positron emission tomography (GAPET) of the myocardium: 18F-FDG-PET to optimize recognition of myocardial hibernation. Nucl Med Commun 19 (1998) 535-545
78. A Khorsand, S Graf and H Frank, Model-based analysis of electrocardiography-gated cardiac (18)F-FDG PET images to assess left ventricular geometry and contractile function. J Nucl Med 44 (2003) 1741-1746
79. WM Schaefer, CS Lipke and B Nowak, Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: A comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging 30 (2003) 545-553
80. WM Schaefer, CS Lipke and B Nowak, Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: Comparison with cardiac MRI. J Nucl Med 45 (2004) 74-79
81. K Rajappan, L Livieratos, PG Camici and DJ Pennell, Measurement of ventricular volumes and function: A comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med 43 (2002) 806-810
82. K Yamashita, N Tamaki and Y Yonekura, Quantitative analysis of regional wall motion by gated myocardial positron emission tomography: Validation and comparison with left ventriculography. J Nucl Med 30 (1989) 1775-1786
83. A Kapur, KA Latus and G Davies, A comparison of three radionuclide myocardial perfusion tracers in clinical practice: The ROBUST study. Eur J Nucl Med Mol Imaging 29 (2002) 1608-1616
84. JJ Mahmarian, TM Boyce, RK Goldberg, MK Cocanougher, R Roberts and MS Verani, Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 15 (1990) 318-329
85. KF Train Van, EV Garcia and J Maddahi, Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med 35 (1994) 609-618
86. KA Brown, Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 83 (1991) 363-381
87. KA Brown, Prognostic value of cardiac imaging in patients with known or suspected coronary artery disease: Comparison of myocardial perfusion imaging, stress echocardiography, and position emission tomography. Am J Cardiol 75 (1995) 35D-41D
88. KA Brown, Prognostic value of myocardial perfusion imaging: State of the art and new developments. J Nucl Cardiol 3 (1996) 516-537
89. ML Ladenheim, BH Pollock and A Rozanski, Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 7 (1986) 464-471
90. JB Gill, TD Ruddy, JB Newell, DM Finkelstein, HW Strauss and CA Boucher, Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 317 (1987) 1486-1489
91. M Mazzanti, G Germano and H Kiat, Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 27 (1996) 1612-1620
92. AS Iskandrian, SC Chae, J Heo, CD Stanberry, V Wasserleben and V Cave, Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 22 (1993) 665-670
93. LJ Shaw, R Hendel and S Borges-Neto, Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4,728 patients. J Nucl Med 44 (2003) 134-139
94. S Giri, LJ Shaw and DR Murthy, Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
95. I Matsunari, G Boning and SI Ziegler, Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18F-fluorodeoxyglucose. J Am Coll Cardiol 32 (1998) 927-935
96. JA Leppo, Myocardial uptake of thallium and rubidium during alterations in perfusion and oxygenation in isolated rabbit hearts. J Nucl Med 28 (1987) 878-885
97. RC Brunken, FV Mody, RA Hawkins, C Nienaber, ME Phelps and HR Schelbert, Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects. Circulation 86 (1992) 1357-1369
98. RO Bonow, V Dilsizian, A Cuocolo and SL Bacharach, Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 83 (1991) 26-37
99. AN Kitsiou, G Srinivasan, AA Quyyumi, RM Summers, SL Bacharach and V Dilsizian, Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization?. Circulation 98 (1998) 501-508
100. M Gursurer, A Emre, H Gercekoglu, S Uslubas, M Aksoy and B Ersek, Long-term prognostic value of stress-redistribution-reinjection Tl-201 imaging in patients with severe left ventricular dysfunction and coronary artery bypass surgery. Int J Cardiovasc Imaging 18 (2002) 125-133
101. DK Glover, M Ruiz and NC Edwards, Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 91 (1995) 813-820
102. DK Glover, M Ruiz, BA Koplan, DD Watson and GA Beller, 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. J Nucl Med 40 (1999) 142-149
103. P Marzullo, O Parodi and B Reisenhofer, Value of rest thallium-201/ technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 71 (1993) 166-172
104. N Takahashi, CP Reinhardt, R Marcel and JA Leppo, Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion. Circulation 94 (1996) 2605-2613
105. MI Travin and SR Bergmann, Assessment of myocardial viability. Semin Nucl Med 35 (2005) 2-16
106. MV Cohen, CP Baines and JM Downey, Ischemic preconditioning: From adenosine receptor of KATP channel. Annu Rev Physiol 62 (2000) 79-109
107. EL Holmuhamedov, S Jovanovic, PP Dzeja, A Jovanovic and A Terzic, Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 275 (1998) H1567-H1576
108. P Crane, R Laliberte, S Heminway, M Thoolen and C Orlandi, Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 20 (1993) 20-25
109. I Matsunari, S Fujino and J Taki, Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: Comparison with rest-redistribution thallium-201. J Am Coll Cardiol 29 (1997) 1226-1233
110. ZX He, R Medrano, JT Hays, JJ Mahmarian and MS Verani, Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial. Circulation 95 (1997) 1799-1805
111. G Bisi, R Sciagra, GM Santoro and PF Fazzini, Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 24 (1994) 1282-1289
112. R Sciagra, G Bisi, GM Santoro, M Agnolucci, O Zoccarato and PF Fazzini, Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography. J Nucl Cardiol 3 (1996) 221-230
113. R Sciagra, G Bisi and GM Santoro, Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 30 (1997) 384-391
114. R Sciagra, M Leoncini, G Marcucci, RP Dabizzi and A Pupi, Technetium-99m sestamibi imaging to predict left ventricular ejection fraction outcome after revascularisation in patients with chronic coronary artery disease and left ventricular dysfunction: Comparison between baseline and nitrate-enhanced imaging. Eur J Nucl Med 28 (2001) 680-687
115. R Sciagra, M Pellegri and A Pupi, Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 36 (2000) 739-745
116. RC Hendel, DS Berman and SJ Cullom, Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 99 (1999) 2742-2749
117. JR Corbett and EP Ficaro, Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol 6 (1999) 54-68
118. DL Bailey, Transmission scanning in emission tomography. Eur J Nucl Med 25 (1998) 774-787
119. M Bocher, A Balan and Y Krausz, Gamma camera-mounted anatomical X-ray tomography: Technology, system characteristics and first images. Eur J Nucl Med 27 (2000) 619-627
120. G Germano, H Kiat and PB Kavanagh, Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
121. EG DePuey and A Rozanski, Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 36 (1995) 952-955
122. JM Links, EG DePuey, R Taillefer and LC Becker, Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT. J Nucl Cardiol 9 (2002) 183-187
123. T Sharir, G Germano and PB Kavanagh, Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100 (1999) 1035-1042
124. MI Travin, GV Heller and LL Johnson, The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol 11 (2004) 253-262
125. JJ Bax, D Poldermans, A Elhendy, E Boersma and SH Rahimtoola, Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 (2001) 141-186
126. K Yoshinaga, K Morita and S Yamada, Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: Comparison with dobutamine stress echocardiography and PET. J Nucl Med 42 (2001) 838-844
127. D Delbeke, S Videlefsky and JA Patton, Rest myocardial perfusion/ metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. J Nucl Med 36 (1995) 2110-2119
128. K Fukuchi, T Katafuchi and K Fukushima, Estimation of myocardial perfusion and viability using simultaneous 99mTc-tetrofosmin - FDG collimated SPECT. J Nucl Med 41 (2000) 1318-1323
129. MP Sandler, S Videlefsky and D Delbeke, Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 26 (1995) 870-878
130. JJ Bax, JH Cornel and FC Visser, Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med 39 (1998) 1481-1486
131. JJ Bax, JH Cornel and FC Visser, Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 28 (1996) 558-564
132. G Srinivasan, AN Kitsiou, SL Bacharach, ML Bartlett, C Miller-Davis and V Dilsizian, [18F]fluorodeoxyglucose single photon emission computed tomography: Can it replace PET and thallium SPECT for the assessment of myocardial viability?. Circulation 97 (1998) 843-850
133. I Matsunari, S Kanayama and T Yoneyama, Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET. Eur J Nucl Med Mol Imaging 29 (2002) 1357-1364
134. I Matsunari, S Kanayama and T Yoneyama, Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using (18)F-FDG and (99m)Tc-sestamibi to assess myocardial viability and function in a single study. Eur J Nucl Med Mol Imaging 32 (2005) 195-202
135. A Kuettner, AF Kopp and S Schroeder, Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with angiographically proven coronary artery disease. J Am Coll Cardiol 43 (2004) 831-839
136. A Kuettner, T Trabold and S Schroeder, Noninvasive detection of coronary lesions using 16-detector multislice spiral computed tomography technology: Initial clinical results. J Am Coll Cardiol 44 (2004) 1230-1237
137. D Ropers, U Baum and K Pohle, Detection of coronary artery stenoses with thin-slice multi-detector row spiral computed tomography and multiplanar reconstruction. Circulation 107 (2003) 664-666
138. AW Leber, A Knez and C Becker, Non-invasive intravenous coronary angiography using electron beam tomography and multislice computed tomography. Heart 89 (2003) 633-639